Category: Medicine
-
Breakthrough: U.K. Approves World’s First CRISPR-Based Gene Therapy
Vertex Pharmaceuticals and CRISPR Therapeutics receive conditional approval for groundbreaking treatment In a groundbreaking development, regulators in the United Kingdom have granted approval for a CRISPR-based gene therapy to treat sickle cell disease and beta thalassemia. This historic decision marks the world’s first authorized therapy utilizing the revolutionary gene-editing technology, ushering in a new era…